Time for Cooperation in Health Economics among the Modelling Community Renée J. G. ArnoldSean Ekins Commentary 29 September 2012 Pages: 609 - 613
Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms Joseph GolecJohn A. Vernon Leading Article 29 September 2012 Pages: 615 - 628
Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer Patricia R. BlankKonstantin J. DedesThomas D. Szucs Review Article 29 September 2012 Pages: 629 - 647
Impact of European Pharmaceutical Price Regulation on Generic Price Competition Jaume Puig-Junoy Review Article 29 September 2012 Pages: 649 - 663
Assessing the Relationship between Computational Speed and Precision Phil McEwanKlas BergenheimJason P. Gordon Original Research Article 29 September 2012 Pages: 665 - 674
Economic Burden of Epilepsy among the Privately Insured in the US Jasmina I. IvanovaHoward G. BirnbaumSue Caleo Original Research Article 29 September 2012 Pages: 675 - 685
Fondaparinux Kate McKeageKatherine A. Lyseng-Williamson Adis Pharmaeconomic Drug Evaluation 29 September 2012 Pages: 687 - 698